• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经影像学在神经退行性疾病的早期诊断中的应用。

Neuroimaging in the early diagnosis of neurodegenerative disease.

机构信息

Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health, 2221 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada.

出版信息

Transl Neurodegener. 2012 Jan 13;1(1):5. doi: 10.1186/2047-9158-1-5.

DOI:10.1186/2047-9158-1-5
PMID:23211024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3506998/
Abstract

Functional imaging may be useful for both the early diagnosis as well as preclinical detection of neurodegenerative disease. Additionally, while structural imaging has traditionally been regarded as a tool to exclude alternate diagnoses, recent advances in magnetic resonance show promise for greater diagnostic specificity. The role of MR and radionuclide imaging in early diagnosis and preclinical detection of dementia and parkinsonism are reviewed here.

摘要

功能成像可能对神经退行性疾病的早期诊断和临床前检测都有用。此外,虽然结构成像传统上被视为排除其他诊断的工具,但磁共振的最新进展显示出提高诊断特异性的希望。本文回顾了磁共振和放射性核素成像在痴呆和帕金森病的早期诊断和临床前检测中的作用。

相似文献

1
Neuroimaging in the early diagnosis of neurodegenerative disease.神经影像学在神经退行性疾病的早期诊断中的应用。
Transl Neurodegener. 2012 Jan 13;1(1):5. doi: 10.1186/2047-9158-1-5.
2
Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives.结构磁共振成像在阿尔茨海默病及其他神经退行性痴呆诊断中的应用:当前成像方法及未来展望
Korean J Radiol. 2016 Nov-Dec;17(6):827-845. doi: 10.3348/kjr.2016.17.6.827. Epub 2016 Oct 31.
3
Neuroimaging in dementia.痴呆症的神经影像学
Semin Neurol. 2008 Sep;28(4):467-83. doi: 10.1055/s-0028-1083695. Epub 2008 Oct 8.
4
Neuroimaging in Dementias.痴呆症的神经影像学
Semin Neurol. 2019 Apr;39(2):188-199. doi: 10.1055/s-0039-1678580. Epub 2019 Mar 29.
5
[Imaging diagnosis of dementia].[痴呆的影像学诊断]
Nihon Rinsho. 2014 Apr;72(4):681-6.
6
Early diagnosis of dementia: neuroimaging.痴呆的早期诊断:神经影像学
J Neurol. 1999 Jan;246(1):16-20. doi: 10.1007/s004150050300.
7
Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.神经退行性认知和行为障碍的影像学检查:痴呆临床实践的实际考量
Handb Clin Neurol. 2016;136:971-84. doi: 10.1016/B978-0-444-53486-6.00050-8.
8
[Symptoms and imaging diagnostics of neurodegenerative dementia].[神经退行性痴呆的症状与影像学诊断]
Radiologe. 2011 Apr;51(4):278-84. doi: 10.1007/s00117-010-2092-8.
9
Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.阿尔茨海默病及其他神经退行性痴呆的多模态成像
J Nucl Med. 2014 Dec;55(12):2003-11. doi: 10.2967/jnumed.114.141416. Epub 2014 Nov 20.
10
Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.优化神经影像学工具在前驱期阿尔茨海默病及相关障碍评估中的应用。
J Alzheimers Dis. 2020;77(3):935-947. doi: 10.3233/JAD-200487.

引用本文的文献

1
Associations Between Trail-Making Test Black and White Performance and Gray Matter Volume in Community-Dwelling Cognitively Healthy Adults Aged 40 to 80 Years.40至80岁社区认知健康成年人中连线测验黑白表现与灰质体积之间的关联
J Clin Med. 2025 Jun 7;14(12):4041. doi: 10.3390/jcm14124041.
2
Bridging neuro-biomarkers and MR imaging: The synergistic role of glial fibrillary acidic protein in early CNS disease diagnosis.连接神经生物标志物与磁共振成像:胶质纤维酸性蛋白在中枢神经系统疾病早期诊断中的协同作用
IBRO Neurosci Rep. 2025 May 3;18:739-753. doi: 10.1016/j.ibneur.2025.04.016. eCollection 2025 Jun.
3
Optical biosensors for diagnosing neurodegenerative diseases.用于诊断神经退行性疾病的光学生物传感器。
NPJ Biosens. 2025;2(1):20. doi: 10.1038/s44328-025-00040-3. Epub 2025 May 2.
4
Hybrid nanostructures for neurodegenerative disease theranostics: the art in the combination of biomembrane and non-biomembrane nanostructures.用于神经退行性疾病治疗学的杂化纳米结构:生物膜和非生物膜纳米结构结合的艺术。
Transl Neurodegener. 2024 Aug 27;13(1):43. doi: 10.1186/s40035-024-00436-7.
5
Clinical Application of Blood Biomarkers in Neurodegenerative Diseases-Present and Future Perspectives.神经退行性疾病中血液生物标志物的临床应用——现状与未来展望。
Int J Mol Sci. 2024 Jul 25;25(15):8132. doi: 10.3390/ijms25158132.
6
Pretargeted imaging beyond the blood-brain barrier.血脑屏障外的预靶向成像。
RSC Med Chem. 2022 Dec 2;14(3):444-453. doi: 10.1039/d2md00360k. eCollection 2023 Mar 22.
7
Pretargeted Imaging beyond the Blood-Brain Barrier-Utopia or Feasible?血脑屏障外的预靶向成像——乌托邦还是可行?
Pharmaceuticals (Basel). 2022 Sep 27;15(10):1191. doi: 10.3390/ph15101191.
8
Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson's disease: a Chinese population-based study.中国人群研究发现,黑质超声回声增强与帕金森病患者的视幻觉相关。
Neurol Sci. 2020 Mar;41(3):661-667. doi: 10.1007/s10072-019-04110-z. Epub 2019 Nov 22.
9
Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.神经丝轻链作为一种生物标志物,与中枢神经系统相关疾病的磁共振成像诊断的相关性。
Mol Neurobiol. 2020 Jan;57(1):469-491. doi: 10.1007/s12035-019-01698-3. Epub 2019 Aug 5.
10
Plausibility of a Neural Network Classifier-Based Neuroprosthesis for Depression Detection via Laughter Records.基于神经网络分类器的神经假体通过笑声记录检测抑郁症的可行性。
Front Neurosci. 2019 Mar 21;13:267. doi: 10.3389/fnins.2019.00267. eCollection 2019.

本文引用的文献

1
Cost of disorders of the brain in Europe 2010.2010 年欧洲大脑疾病负担成本。
Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15.
2
MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study.MRI 测量可预测无法分类的帕金森病中的 PSP:一项队列研究。
Neurology. 2011 Sep 13;77(11):1042-7. doi: 10.1212/WNL.0b013e31822e55d0. Epub 2011 Aug 10.
3
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.特发性快速眼动睡眠行为障碍患者黑质纹状体功能的连续多巴胺转运体成像:一项前瞻性研究。
Lancet Neurol. 2011 Sep;10(9):797-805. doi: 10.1016/S1474-4422(11)70152-1. Epub 2011 Jul 28.
4
Functional network disruption in the degenerative dementias.退行性痴呆症的功能网络破坏。
Lancet Neurol. 2011 Sep;10(9):829-43. doi: 10.1016/S1474-4422(11)70158-2. Epub 2011 Jul 21.
5
White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study.特发性快速眼动睡眠行为障碍的白质和灰质异常:一项弥散张量成像和基于体素的形态测量研究。
Ann Neurol. 2011 Feb;69(2):400-7. doi: 10.1002/ana.22245. Epub 2010 Dec 28.
6
Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.淀粉样蛋白 PET 成像在轻度认知障碍患者中的应用:一项为期 2 年的随访研究。
Neurology. 2011 Mar 22;76(12):1085-90. doi: 10.1212/WNL.0b013e318212015e. Epub 2011 Feb 16.
7
Multimodal classification of Alzheimer's disease and mild cognitive impairment.阿尔茨海默病和轻度认知障碍的多模态分类。
Neuroimage. 2011 Apr 1;55(3):856-67. doi: 10.1016/j.neuroimage.2011.01.008. Epub 2011 Jan 12.
8
Dopamine turnover increases in asymptomatic LRRK2 mutations carriers.无症状 LRRK2 突变携带者的多巴胺周转率增加。
Mov Disord. 2010 Dec 15;25(16):2717-23. doi: 10.1002/mds.23356.
9
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.帕金森病黑质纹状体特征的磁共振成像标志物。
Brain. 2010 Nov;133(11):3423-33. doi: 10.1093/brain/awq212. Epub 2010 Aug 23.
10
Comparing predictors of conversion and decline in mild cognitive impairment.比较轻度认知障碍转归和衰退的预测因素。
Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30.